Janus Henderson Horizon Biotechnology Fund A2 HSGD

WKN A3EPE4 | ISIN LU1984712759 |  Fonds
Factsheet

Fonds

ISIN Name Performance Volatilität Sharpe Ratio
1 LU1540961759 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund A Cap USD -3,12 % +18,76 % -0,29
2 LU2026682919 Candriam Equities L Biotechnology, V2 - Capitalisation -4,77 % +20,45 % -0,34
3 LU1540962054 HBM UCITS (LUX) FUNDS - HBM Global Biotechnology Fund P Cap USD -3,62 % +19,58 % -0,30
4 LU0942225912 Candriam Equities L Biotechnology, R - Capitalisation -4,29 % +20,41 % -0,32
5 LU0317020203 Candriam Equities L Biotechnology, V - Capitalisation -5,02 % +20,30 % -0,36
34 LU1984712759 Janus Henderson Horizon Biotechnology Fund A2 HSGD -12,14 % +27,97 % -0,51
79 LU0767968745 Bellevue Funds (Lux) - Bellevue Obesity Solutions I GBP - Accumulating -10,57 % +11,98 % -1,07
80 DE000A3DCA95 BIT Biotech Opportunities S -35,23 % +30,99 % -1,21
81 DE000A3DCBA0 BIT Biotech Opportunities I-II -35,36 % +30,97 % -1,21
82 LU0415392835 Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating -14,91 % +13,79 % -1,24
83 LU0415392595 Bellevue Funds (Lux) - Bellevue Obesity Solutions B CHF - Accumulating -15,51 % +13,79 % -1,29